Today is March 28, 2024.
All times in Eastern Daylight Time.
-
Steel Partners Holdings Reports Fourth Quarter and Full Year Results
NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (NYSE: SPLP), a diversified global holding company, today announced operating results for the fourth quarter and year ended December 31, 2023... more »
-
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glu... more »
-
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the presen... more »
-
OFS Credit Company Announces Financial Results for the First Fiscal Quarter 2024
CHICAGO--(BUSINESS WIRE)--OFS Credit Company, Inc. (Nasdaq: OCCI) (“OFS Credit,” the “Company,” “we,” “us” or “our”), an investment company that primarily invests in collateralized loan obligation ... more »
-
Belden’s Hiran Bhadra Promoted to Sr. Vice President, Strategy & Technology
ST. LOUIS--(BUSINESS WIRE)--Belden Inc. (NYSE: BDC), a leading global supplier of digitization and network infrastructure solutions, announced today the promotion of Hiran Bhadra to the role of Sr.... more »
-
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, ... more »
-
Getaround Announces Inducement Awards to New CEO, Eduardo Iniguez, in Accordance with NYSE Rule 303A.08
SAN FRANCISCO--(BUSINESS WIRE)--Getaround (NYSE: GETR), the world's first connected carsharing marketplace, announced that on February 26, 2024, its Board of Directors granted to its new Chief Exec... more »
-
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it has dosed the first subjects in a Phase 1/2a double-blinded, placebo-controlled, dose-escal... more »
-
VSE Corporation Declares Quarterly Cash Dividend
ALEXANDRIA, Va.--(BUSINESS WIRE)--VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC), a leading provider of aftermarket distribution and repair services, announced that the Company’s Board of ... more »
-
APi Group Announces Participation in the 2024 J.P. Morgan Industrials Conference
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced that its senior leadership will be participating in a fireside chat during the 2024 ... more »
-
SkyWater Expands Board of Directors with Appointment of Dennis Goetz and Joseph Humke
BLOOMINGTON, Minn.--(BUSINESS WIRE)--SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, today announced the appointment of two accomplished professionals to its board o... more »
-
FiscalNote to Report Full Year and Fourth Quarter 2023 Financial Results on March 12
WASHINGTON--(BUSINESS WIRE)--FISCALNOTE TO REPORT FULL YEAR AND FOURTH QUARTER 2023 FINANCIAL RESULTS ON MARCH 12 more »
-
Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced topline results from PHOENIX, a global, 48-week, randomized, placebo-contr... more »
-
Genesco Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Results
NASHVILLE, Tenn.--(BUSINESS WIRE)--GENESCO INC. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR RESULTS more »
-
InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024 more »
-
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference Americas
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commerciali... more »
-
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presente... more »
-
SSR Mining Announces Changes to Executive Leadership Team
DENVER--(BUSINESS WIRE)--SSR Mining Inc. (NASDAQ/TSX: SSRM, ASX: SSR) ("SSR Mining" or the “Company") announces the reorganization of key roles and responsibilities within its executive leadership ... more »
-
Cloudflare Doubles Down on Middle East; Expands Presence and Team to Support Growing Customer Demand
SAN FRANCISCO & DUBAI, United Arab Emirates--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), the leading connectivity cloud company, today announced it is pushing forward with aggressive investment ... more »
-
Cool Company Ltd. - Ex Dividend
HAMILTON, Bermuda--(BUSINESS WIRE)--The shares in Cool Company Ltd. (NYSE: CLCO / CLCO.OL) will be traded ex dividend of $0.41 per share for the fourth quarter of 2023 as of today, March 8, 2024. T... more »
-
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of The Chemours Company (CC) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of The Chemours Company (“Chemours” or t... more »
-
Lost Money in Infinera? Gibbs Law Group Investigates Potential Securities Law Violations
OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Infinera Corporation dropped over 11% on March 7, 2024, after the company found “material weaknesses” in its financial reporting—following an independent... more »
-
The Law Offices of Frank R. Cruz Announces Investigation of Xcel Energy Inc. (XEL) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Xcel Energy Inc. (“Xcel” or the “Company”) (NASDAQ: XEL) on behalf of investors concerning the Company’s... more »
-
UnitedHealth Group Update on Change Healthcare Cyberattack
--(BUSINESS WIRE)--UnitedHealth Group shares update on mitigating the impact of the cyberattack on the U.S. health system and Change Healthcare. more »
-
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avid Bioservices, Inc. (“Avid Bioservices” or “t... more »
|
|